Key facts
- This page summarizes Michael Auerbach's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Jan 2022, 15:30.
Michael Auerbach - 14 Jan 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)
- Reporting relationship
- Director
- Issuer ticker
- ATAI
- Reported as of
- 14 Jan 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Jan 2022, 15:30:13 UTC
- Prior SEC filing
- 04 Jan 2022
- Next SEC filing
- 02 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Barrett, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Auerbach filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 19 Jan 2022.
Change
- Previous filing in this sequence was filed on 04 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATAI
transaction
Common Shares
Other
- Transaction value
- $0
- Shares
- -5,559,808
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Jan 2022
- Ownership
- By Subversive ATAI, LLC
- Footnotes
- F1, F2
ATAI
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,666
- Date
- 14 Jan 2022
- Ownership
- Direct
- Footnotes
- F3
ATAI
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 519,642
- Date
- 14 Jan 2022
- Ownership
- By M3 Daat, LLC
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents a pro-rata distribution in-kind by Subversive ATAI LLC for no consideration to its members.
Footnote F2
Mr. Auerbach serves as Managing Member of Subversive ATAI, LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Subversive ATAI, LLC.
Footnote F3
The Reporting Person's Form 4 filed on June 24, 2021 inadvertently attributed a purchase of 4,666 Common Shares to Subversive ATAI, LLC. Following the reported transaction, the Reporting Person directly beneficially owned 4,666 Common Shares as reported herein.
Footnote F4
Reflects the acquisition of Common Shares by M3 Daat, LLC in connection with the pro-rata distribution in-kind described in footnote 1 above, which was exempt from reporting pursuant to Rule 16a-13.
Footnote F5
Mr. Auerbach is a member of M3 Daat, LLC and has sole voting and investment power with respect to the shares held by M3 Daat, LLC. Mr. Auerbach disclaims beneficial ownership over the Common Shares held by M3 Daat, LLC, except to the extent of his pecuniary interest.